Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Fort Myers, FL
NPI: 1366438855Primary Practice Location
St Marks Surgical Center LLC
6820 International Center Blvd, Fort Myers, FL
Primary Employer
Eye Associates of Fort Myers
eyeassociatesonline.com
HQ Phone
Get M.D. Stephen's Phone Numberphone_androidMobile
Get M.D. Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 802 | 1,190 |
| 2 | 92134Diagnostic imaging of retina | 594 | 660 |
| 3 | 92250Photography of the retina | 363 | 375 |
| 4 | 92012Eye and medical examination for diagnosis and treatment, established patient | 257 | 472 |
| 5 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 195 | 195 |
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert.
Authors: Ravi Patel, Maria Rosselson, Subba Gollamudi, Michael Goldstein, John Stephens
Journal: Clin Ophthalmol
Publication Date: 2022-08-06
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: 0.02% Betamethasone Sodium Phosphate, DRUG: 0.04% Betamethasone Sodium Phosphate
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 Ophthalmic Suspension dosed BID, DRUG: KPI-121 1% Ophthalmic Suspension dosed BID
